Monitoring a population for a disease requires the hosts to be sampled and tested for the pathogen. This results in sampling series from which to estimate the disease incidence, i.e. the proportion of hosts infected. Existing estimation methods assume that disease incidence is not changing between monitoring rounds, resulting in underestimation of the disease incidence. In this paper we develop an incidence estimation model accounting for epidemic growth with monitoring rounds sampling varying incidence. We also show how to accommodate the asymptomatic period characteristic to most diseases. For practical use, we produce an approximation of the model, which is subsequently shown accurate for relevant epidemic and sampling parameters. Both the approximation and the full model are applied to stochastic spatial simulations of epidemics. The results prove their consistency for a very wide range of situations.
Introduction 1
Monitoring programs are used to keep track of the invasion and spread of human, animal 2 and plant pathogens. They are often structured in discrete rounds of inspection, during 3 which subsamples of the host population are assessed for disease status (Parnell et al., 4 2017). Given a sequence of monitoring rounds, a key question in interpreting these data 5 is the estimation of the incidence 1 of the disease in the host population. There are two 6 special cases of this general question that have received some attention. 7 Firstly, monitoring is often motivated by the need for early responses to enable 8 eradication or containment. For example, early detection of the disease permits reduced 9 cullings of animal and plant hosts (Carpenter et al., 2011; Cunniffe et al., 2015 Cunniffe et al., , 2016 , as 10 well as reduced resorts to emergency quarantines or travel restrictions for human hosts 11 (applied e.g. for SARS, Smith, 2006) . 12 Secondly, monitoring is frequently motivated by the desire of proving disease absence 13 from a host population (Caporale et al., 2012) , which is of key importance for the 14 transport and trade of hosts. The main question then concerns the sufficient sample 15 size (Cannon, 2002) . An example of this is the practical "rule of three" (Louis, 1981 ; 16 Hanley & Lippman-Hand, 1983). It gives the upper bound of the 95% confidence 17 interval (CI) of the incidence when all of the N sampled hosts are assessed as healthy: 18 q 95 = 3/(N + 1). Estimating a disease incidence (noted q hereafter), or proving its 19 absence, is mostly interesting during the early stages of epidemics, i.e. when incidences 20 are low and containment measures are still promising. 21 Simple practices like the "rule of three" make the assumption that the samples 22 are independent binomial draws of probability q. However, epidemics are structured 23 processes, and samples are very likely to carry dependencies to those structures. For 24 example, by pooling all the samples together, we neglect the fact that early monitoring 25 rounds have most likely sampled a lower incidence q than the current one, resulting in 26 an underestimation of the incidence. An alternative and unbiased solution consists in 27 estimating q only from the last round to date. But obviously, such a poor use of data 28 would only be tolerable in cases where the monitoring interval and epidemic growth rate 29 are both very large, so that the previous monitoring rounds can be deemed uninformative 30 of the last one. The temporal dependence of samples has been addressed by Metz et al. 31 (1983) in the design of appropriate monitoring programs, as well as by Bourhis et al. 32 (2018) for the incidence estimation problem in the specific case of disease absence, i.e. 33 when all samples return healthy.
34
Making use of all monitoring data, we propose here a generalised solution to the 35 incidence estimation problem. Building on the simple logistic equation, we develop an 36 estimation model that accounts for the evolution of the disease during the monitoring 37 period. Following the idea of the rule of three, and in the way of Parnell et al. (2012) and 38 Alonso Chavez et al. (2016), we produce an approximation of this model. Its derivation 39 only requires simple algebraic operations which makes it more suitable for practitioners. 40 The full model and its approximation are shown accurate when tested against stochastic 41 sampling of logistic epidemic simulations. Finally, they are taken one step further and 42 conclusively tested against spatially explicit stochastic simulation models.
43

Material and Methods
44
Monitoring a population for a disease results in sampling series like Table 1 . We define 45 K as the number of monitoring rounds iterated in time. N k is the sampling size of 46 monitoring round k, i.e. the number of hosts whose pathological status is assessed at 47 time t k . M k is the number infected hosts detected during round k. Finally, ∆ k is the 48 time interval between monitoring rounds k and k + 1. 
49
Considering q the disease incidence in the population, the probability of any sampling 51 size N and respective result M , is given by the binomial probability density function
(1)
2/12
A more general form, accounting for the occurrences of false positives and negatives in 53 the detection process, would be
where θ f n and θ f p are respectively the rates of false negatives and false positives. But 55 we will not expand this further here.
56
In a practical context, q is the variable that we want to estimate from samples 57 characterised by their size N and their outcome M . To this end we use Bayes' rule:
where P (q|M ) is the probability density of q given M and N . Assuming no information 59 on the incidence before sampling, we set a uniform prior P (q), simply resulting in 60 P (q|M ) ∝ P (M |q) (Gelman et al., 2003) .
61
K monitoring rounds 62
To account properly for the dynamic incidence between monitoring rounds, our proposi-63 tion is to inform the binomial probability density with an epidemiological component, 64 noted Z k :
where M on the left-hand side represents the whole sampling series, i.e M 1 , M 2 ,...,M K . 66 In Eq. 4, the parameter Z k ∈ [0, 1] modulates the value of q for the samples to be 67 compared to the disease incidence that was actually found in the population when 68 they were made (i.e. at time t k ). For the last monitoring round, Z k=K = 1, and then 69 decreases with k < K. 70 We assume that the disease incidence, q, evolves logistically (van der Plank, 1963; 71 Murray, 2002) in time t as: 72 q(t) = q 0 e rt 1 + q 0 (e rt − 1)
,
where q 0 is the incidence at time t 0 and r is the epidemic growth rate. To include this 73 logistic growth into the binomial probability density, we define Z k as:
where t k = K i=k −∆ i are the sampling dates, with the last date defined as t K = 0. Eq. 75 5 can be fed negative time values to derive incidence backward in time (so that q 0 in Eq. 76 5 is in fact the incidence at the end of monitoring, i.e. the one to estimate).
77
Similarly to the case of one monitoring round, we use Bayes' rule to get the un-78 normalised posterior distribution P (q|M ). Practically, it is given by Eq. 4, which is 79 computed for a discretised array of q ∈ [0, 1], and from which quantiles can be derived 80 (a method called grid approximation, see e.g. Kruschke, 2014 ). This estimation model 81 has been deployed as an online app (see Supplementary Materials for details).
82
A useful approximation 83
As mentioned in the introduction, the upper bound of the confidence interval (CI) is a 84 useful measure of the highest, still likely, incidence we can expect in the population given 85 3/12 the outcome of our monitoring program. Deriving an approximation from the estimation 86 model previously described proved itself intractable. However, various methods exist for 87 approximating the CI of a binomial probability density (Wallis, 2013) , and they appeared 88 to fit the binomial-shaped probability density given by Eq. 4. After preliminary testing 89 of those methods, we choose the Agresti-Coull interval for its accuracy for low incidences 90 (Agresti & Coull, 1998) . The Agresti-Coull interval is defined as
and then
where q X is the upper limit of the X% CI and z is the corresponding 1 − α/2 quantile 93 of the standard normal distribution. For the one-sided 95% CI that we used in the 94 examples hereafter, z = 1.645.
95
As previously, the estimation of q X needs to account for the epidemic growth. Because 96 of the density dependence of the logistic equation, we cannot ground this newZ k on the 97 logistic model, as it would need q to estimate q. Therefore, we assume an exponential 98 growth of the disease in the population. In practice, this assumption is realistic as, 99 during early infection, the epidemic growth is exponential, even according to the logistic 100 model (van der Plank, 1963). Then,Z k quantifies the disease evolution between rounds 101 as
Finally, we aggregate the samples together with respect to the epidemic growth viaZ k : 103
These aggregated values of M and N are then substituted in Eqs. 7 and 8 to derive 104 q X . By scaling the size of the historic samples with the disease incidence they actually 105 sampled, we adjust their contribution to the total sampling effort. The min and max 106 operators in Eq. 8 are added to deal with the possibility of having N < M for some 107 values ofZ k .
108
As discussed in the introduction early detection of epidemics and the establishment 109 of disease absence have received some attention in the epidemiological literature. Two 110 specific approximations have been produced for the estimation of the disease incidence 111 (1) when the first infected hosts are detected (first discovery event, Parnell et al., 2012), 112 and (2) while no infected hosts have yet been detected (sampling for disease absence, 113 Bourhis et al., 2018). See Supplementary Materials for details. The general estimation 114 model we provide in this study encompasses those specific contexts but extends to any 115 sampling series, being irregularly structured or not, and whatever their outcoming M k . 116
Asymptomatic period 117
In most diseases, infected hosts produce symptoms after an asymptomatic period. Often, 118 asymptomatic hosts contribute to the epidemic dynamics by spreading the disease while 119 still undetectable (cryptic) when sampled. The logistic equation handles this period, 120 noted σ, as
where q T is the total incidence of the disease, while q becomes the detectable incidence 122 (in our problem, q is the sampled incidence and q T the estimated one). Hence, Eq. 6 123 becomes
Therefore, Z k now expresses the ratio q(t k )/q T (t K ), instead of q(t k )/q t (t K ), and is then 125 no longer equal to 1 for the last round (if σ > 0). For the exponential approximation, 126 the Eq. 9 simply becomes
Testing the model 128
The consistency of the full model and the accuracy of its approximation are first tested 129 against simulations of stochastic sampling on non-spatial logistic epidemics. We consider 130 a uniform distribution of incidences q T that we want to estimate individually. For each 131 one of them, a monitoring program is designed with N k and ∆ k drawn from Poisson 132 distributions of mean N and ∆. From the logistic equation (Eq. 5), the detectable 133 incidence q is derived for every sampling dates t k . Then binomial draws with probability 134 p = q(t k ) and size n = N k simulate the sampling process of the hosts, resulting in M k . 135 For every q T an exact upper bound of its CI, q X , is derived with the full model, while an 136 approximated one,q X , is derived with the approximation. A relevant test then consists 137 in checking that the upper limits of the X% CI are above q T in X% of cases. This test 138 is done for contrasted values of the sampling (N and ∆) and epidemic parameters (r 139 and σ).
140
The full model and its approximation are also tested against a spatial stochastic 141 simulation model. In this case, the epidemics are no longer modelled with the logistic 142 equation but through a transmission rate and a dispersal kernel of the pathogens. To 143 this end, the hosts are distributed in a 2D-space and aggregated randomly in field-144 like structures mimicking the distribution of the trees in an orchard. Details on this 145 landscape model are given as Supplementary Material. The epidemic progress follows an 146 exponential power kernel (Rieux et al., 2014) . The probability of a susceptible individual 147 to become infected in a unit of time is then given by
Where s is a susceptible host among the set of all susceptible hosts S. Similarly, i 149 and I represent the infected hosts. A is the area occupied by one host and Γ is the 150 Gamma function. β is the probability of infection, θ is the dispersal scale and b is a 151 shape parameter (producing fat-tailed kernels for b < 1). The coordinates x mark the 152 location of the hosts. Following Klein et al. (2006) , the mean dispersal distance for this 153 2D kernel is given by:
The spatial dynamics are simulated with the τ -leap Gillespie algorithm (Keeling & 155 Rohani, 2008). Three sampling methods of increasing realism are tested: random (i.e. 156 host locations have no impact on sampling), stratified (i.e. sampling equally distributed 157 among fields) and systematic (i.e. sampling occurs every n hosts along ranks). As 158 no effect of the sampling method is observed, results are shown for the random one. 159 Apart from this, the model and its approximation are evaluated in the same way as the 160 non-spatial case. Figure 1 illustrates the effects of the epidemic and sampling parameters on the resulting 164 probability densities of the incidence and upper quantiles q 95 . Increasing M , the number 165 of positive/infected hosts in the sample, unsurprisingly increases the estimated incidence. 166 Increasing the sample size N reduces the uncertainty in the estimates. Increasing the 167 sampling interval ∆ decreases their impact on the estimation. This reflects the fact 168 that samples taken further back in time are less informative of current disease incidence. 169 Regarding the epidemic parameters, the growth rate r and the asymptomatic period σ 170 (not shown on Figure 1 for dimensional reasons) have very similar effects to ∆. They both 171 increase the estimated incidence by decreasing the impact of the historic samples, i.e. 172 the ones which sample lower incidences q. By doing that, ∆, r and σ reduce the effective 173 sample size (i.e. K k=1 N k Z k ), which also contributes in increasing the uncertainty on 174 the estimates (i.e. producing densities with larger variance). Test against logistic epidemics 176 Figure 2 shows the distribution of the exact and approximated upper bounds of the 177 95% CI, q 95 andq 95 , for uniform distributions of q T and different values of the epidemic 178 and sampling parameters. The full model, which like the simulations builds on the 179 logistic equation, behave exactly as expected: it ensures that 95% of the q 95 are 180 above their respective q T , for every set of parameters tested. On the other hand, the 181 approximation displays another behaviour easily explained by its underlying exponential 182 growth model. For the low incidences which are relevant to practice (i.e. say q T < 0.25), 183 the approximation is accurate (the distributions of q 95 andq 95 do overlap). For higher 184 6/12 incidences, i.e. when the logistic growth decelerates unlike the exponential growth, the 185 approximation tends to overestimate the incidence (increasingly with r, σ and ∆).
186
Another model behaviour is of particular interest: when r and σ are large (cf. the 187 rightmost column), we observe that the estimated q 95 andq 95 do not align well with the 188 diagonal for small incidences q T . For those cases of very hazardous pathogens with high 189 epidemic growth rates and long asymptomatic periods, the sampling size N is too small 190 to allow discrimination between the non-detection cases (i.e. the one for which all the 191 M k = 0), and that larger sampling effort is needed for the estimation to be useful.
192
Although increasing r and σ accelerates the divergence between the logistic and 193 the exponential curves, the approximation appears accurate for early infections even 194 considering very high values of epidemic parameters such as r = 0.1 day −1 or σ = 195 100 days.
196 Figure 2 . Estimation of q 95 andq 95 from sampling series of non-spatial epidemics, i.e. simulated with the logistic equation (Eq. 5). These estimations are made for contrasted values of sampling and epidemic parameters (and for K = 5 monitoring rounds). Using here the 95% CI, we expect 95% of the estimated q 95 andq 95 to be above the actual incidence in the field at the end of monitoring q T , i.e. above the oblique black line. The inserted texts summarise these scores for the full model (in red) and its approximation (in blue).
Test against spatial epidemics 197
When locating the hosts in space, the epidemic becomes driven by two new elements: 198 the dispersal range of the pathogen and the intensity of host clustering (Brown & Bolker, 199 2004) . Both determine how easily the pathogen spreads across the landscape or remains 200 restricted to a local group of hosts. Random distributions of hosts and long dispersal 201 ranges result in smooth progressions of the pathogen across the landscape, following 202 a logistic-like curve. However, as the dispersal range decreases and host aggregation 203 increases, the simulated epidemics will tend to include interruptions between periods 204 of seemingly logistic growth within host clusters. Questions then arise regarding the 205 performance of our estimation model on such epidemics.
206
In this regard, the estimation model and its approximation are tested for varying host 207 7/12 aggregations and dispersal ranges. Host aggregation is summarised by µ, the number of 208 hosts in a field (sensu host cluster). For a given landscape-scale population of hosts, 209 more hosts by fields means fewer but more populated fields (see the Supplementary 210 Material for an illustration). The dispersal scale θ is translated in terms of mean dispersal 211 distance δ (see Eq. 15), while µ is translated in terms of d, a landscape metric measuring 212 the mean minimal distance between the fields within a landscape (see Euclidean Nearest 213 Distance in Leitao et al., 2006) . These estimations are made for varying dispersal ranges θ and hosts aggregations µ, while maintaining constant values of the non-spatial parameters (N = 100, ∆ = 30, σ = 30, K = 5, as well as β = 75 and b = 0.45 for the remaining kernel parameters). For better understanding, θ and µ are shown with their distance translation in meters, δ and d. The identified logistic growth rate r is given for each experiment. The resulting distributions of q 95 andq 95 are qualitatively similar for other realistic values of the fixed parameters.
In the same way as Figure 2 , Figure 3 shows the performance of the model and its 215 approximation for gradients of dispersal scales θ (in columns) and host aggregations µ 216 (in rows). For each parameter set θ and µ (i.e. each panel in Figure 3 ), 50 epidemics are 217 first simulated for 50 different landscapes in order to identify the value of r producing 218 the best fitting logistic curve. This r then informs the incidence estimation model and its 219 approximation for the subsequent testing set of 2000 epidemics and landscapes. Most of 220 the figure is in agreement with expectations: the estimated q 95 do align neatly above the 221 diagonal, showing in practice the accuracy of the estimation model. The approximation 222 appears to be a good simplification of the full model for early detection. However, the 223 estimation model also produces overestimations of the incidence, in bottom row and 224 left column (i.e. where the dots do not align above the diagonal), cases for which the 225 distance between host clusters (quantified by d) is too large for the pathogen dispersal 226 range (quantified by δ), restricting the usefulness of the model to cases where d/δ ≤ 0.5. 227
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We notice also that p(q T < q 95 ) can be below the 95% expectation. As stochasticity 228 scatters the realised epidemic curves symmetrically around the fitted logistic one, such 229 effect is mechanical. Yet, this is of no practical concern as, when various epidemic growth 230 estimates are available for a disease, the highest is chosen for caution (and not the mean 231 as we did here).
232
Discussion
233
The model developed in this paper is suitable for many monitoring designs, including 234 those with irregular sampling sizes and time intervals between rounds. The model 235 weights the monitoring outcomes according to an estimation of the population incidence 236 at their respective sampling time, before aggregating them into a single binomial-shaped 237 probability density of the incidence whose quantiles have practical interests. The model 238 is directly applicable for situations in which surveillance is not built on the self-reporting 239 of symptomatic hosts, which makes it appropriate for most animal and plant species.
240
Deriving the probability density of the incidence from the sampling series is compu-241 tationally inexpensive, but still requires the use of a computing language. Therefore, 242 we have produced an online app interfacing the full model as exhaustively as possible, 243 as well as an approximation of the model which can be derived with simple algebraic 244 operations. Our intention is to equip the widest audience of practitioners with this 245 incidence estimation capability. The approximation is as flexible as the original model, 246 and we have shown that its inaccuracies are restricted to high level of incidences that 247 are less relevant when dealing with emerging epidemics. However, in case such high 248 incidence estimation is needed, we have seen that the approximation is conservative, i.e. 249 biased towards an overestimation of disease progress.
250
The model relies on the simple and deterministic logistic equation. That it is 251 consistent with more complex systems is not obvious. The tests presented here against 252 spatial, stochastic and non-logistic based simulations of epidemics, are very promising. 253 They show that our non-spatial model is robust against the decisive impact of spatiality 254 and stochasticity. The model gives accurate estimates of the disease incidence for 255 most simulated epidemics. However, highly aggregated host distributions, as well as 256 short distance dispersing pathogens, support epidemics that diverge from the logistic 257 equation. In those contexts, the disease progression across the landscape is not steady 258 but punctuated by rare events: the pathogen jumps between distant host clusters. 259 Then, the very distinctive trajectories this epidemic can take do not simplify well into 260 a single logistic curve. In such cases, reduced pathogen dispersal and increased host 261 aggregation result in the habitat fragmentation of the pathogen. This allows us to 262 consider the pathogen dispersal between distant host clusters as a primary infection. 263 Theoretically, we consider that the epidemic is composed of multiple smaller epidemics 264 running simultaneously, that can be dealt with individually, or be given multiscale 265 considerations (as in Cameron & Baldock, 1998; Coulston et al., 2008) . 266 Recent technological innovations are changing epidemiological surveillance for more 267 timely and exhaustive censuses. For example, the monitoring of human epidemics is 268 already augmented by the supervision of social networks (Chen et al., 2014) and internet 269 search queries (Yuan et al., 2013; Yang et al., 2015) . Tree monitoring could also be 270 assisted by satellite high-resolution imagery (Li et al., 2014; Salgadoe et al., 2018) . Those 271 forthcoming innovations will still need robust and epidemiologically informed estimation 272 methods and, even featuring continuous monitoring, there is no reason to see them 273 incompatible with an adaptation of our model. However, in any foreseeable future, most 274 contagions will still be monitored through discrete and censored inspections and hence, 275 remain within the immediate scope of the estimation model presented here. 
